Home Dialysis Central
...everything you need to know about doing dialysis at home.
Journal watch
Alternate night nocturnal HD in Australia
Every other night nocturnal HD is a popular option in Australia. Patients who use this option have lower phosphorus levels and better volume control and well-being—at about the same cost as standard in-center HD.
Read more | (added Dec 22, 2011)
More home HD in Australia and New Zealand—because doctors believe in it
In contrast to the rest of the world, Australia and New Zealand have an average of 12.9% of patients using home HD. Why? Because nephrologists, nurses, and funding agencies hold strong beliefs in the clinical and economic benefits of this option.
Read more | (added Dec 22, 2011)
Nocturnal HD protects arteries
In a year-long study, 60 people on standard in-center HD were compared to a similar group of 60 people on 8-hour nocturnal HD three nights per week. The nocturnal group needed fewer blood pressure medications and had lower serum phosphorus and calcium-phosphorus products. Their arteries were less stiff than those of people doing standard in-center HD.
Read more | (added Dec 22, 2011)
Green dialysis – reducing energy use and landfill space
Worldwide, dialysis uses an estimated 156 billion liters of water per year, 1.62 billion kilowatt hours of power, and generates 625,000 tons of plastic waste. Our own Dr. John Agar suggests ways to reduce the carbon footprint of dialysis through water conservation, solar power, and other ideas.
Read more | (added Dec 22, 2011)
HD offers better survival than PD for congestive heart failure
A study of 933 people with CHF on PD and 3468 on HD in the French dialysis registry found that for people with congestive heart failure, HD is a safer choice. The risk of death with PD was 48% higher.
Read more | (added Dec 22, 2011)
Longer life on PD with statins
A study from Korea has found that people on PD who were prescribed statin drugs (used for high cholesterol) had a 41% lower risk of death than those who were not given statins. The effect held true for people who had diabetes as well. Future randomized, controlled studies are suggested.
Read more | (added Dec 22, 2011)
Mupirocin beats polysporin triple ointment (P3) for preventing PD catheter infections
In an 18-month long randomized, controlled study, twice as many patients had redness at the PD catheter exit site and more fungal infections occurred in those using P3 than mupirocin.
Read more | (added Dec 22, 2011)
Cycler PD done longer than manual PD
Among 179 people doing CAPD and 441 using cyclers, survival and the rates of loss of residual kidney function and peritonitis were about the same. But technique survival was significantly better among those who used a cycler.
Read more | (added Dec 22, 2011)
Protein intake improves after a switch from standard to nocturnal HD
After 8 months of nocturnal HD, 15 people who switched from standard in-center HD had significantly higher protein intake. Their phosphate intake rose as well—but their serum phosphate levels did not, even without binders.
Read more | (added Nov 28, 2011)
Adsorptive column removes B2m
Too-high levels of B2m cause amyloidosis in people on dialysis, with joint and bone pain. In Japan, people dialyzed using the Lixelle S-15 adsorptive column had significantly less B2m in their blood after a year of 3x/week treatments. They were also stronger and had less joint pain.
Read more | (added Nov 28, 2011)
Our sponsors
Home Dialysis Central is made possible through the generous annual contributions of our Corporate Sponsors. Learn more about becoming a Corporate Sponsor.
